Category: Specialty Drugs

A patient discusses psoriasis treatment options and psoriasis medication costs with a dermatologist

Psoriasis Action Month: Finding Help with Medication Costs

Psoriasis is a chronic autoimmune condition that speeds up the life cycle of skin cells, causing raised, scaly patches that can itch, crack, and hurt. It affects more than 7.5 million adults in the United States, according to the National Psoriasis Foundation, and for many people it’s a lifelong condition. Today’s treatments — especially the newer biologics — can clear skin dramatically, but psoriasis medication costs are a real barrier: these are often specialty medications with high price tags. This Psoriasis Action Month, we’re highlighting the treatments used and, more importantly, the programs that help make them affordable. Understanding psoriasis […]

A patient and oncologist discuss Rasonque cost and treatment support options in a supportive consultation

How to Afford Rasonque (daraxonrasib), a New Pancreatic Cancer Treatment

Rasonque (daraxonrasib) is a newly approved treatment for advanced pancreatic cancer — and for patients and families facing this diagnosis, questions about cost can add to an already overwhelming time. This post explains what Rasonque is and walks through the programs that can help with the Rasonque cost. What Rasonque is Rasonque (daraxonrasib) is a once-daily pill made by Revolution Medicines. According to the FDA, it was approved on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma — the most common form of pancreatic cancer — who have already received at least one prior treatment, or who are not […]

New Alzheimer’s Drugs Proven to Work

Alzheimer’s disease is a neurological disease that is the most common cause of dementia. It causes progressive destructive and irreversible changes in the brain. A common feature is the accumulation of a protein called amyloid-β in the form of plaques and tau tangles. Both are thought to cause brain cell death. Although among the most likely candidates, they have not yet been shown to be the cause of Alzheimer’s disease. In a blog from 2 years ago a newly approved drug for Alzheimer’s disease named aducanumab was discussed. At the time I thought the medication had not been proven to […]

New Alzheimer’s Disease Treatments — The Eye of the Beholder

There has been a lot in the news lately about aducanumab (Aduhelm), a new monoclonal antibody treatment for Alzheimer’s disease.    Alzheimer’s disease is a neurological disease and is the most common cause of dementia. It causes destructive, progressive, and irreversible changes in the brain. A common feature is the accumulation of a protein called amyloid-β in the form of plaques and tau tangles. Both are thought to cause cell death, but they have not yet been shown to be the cause of Alzheimer’s disease.   Aducanumab (Aduhelm), a drug that reduces amyloid-β plaques, was approved by the FDA on […]

Transgender Awareness Week & Remembrance Day

Transgender Awareness Week falls between November 13-19 every year and is meant to help raise visibility of a vulnerable and underserved community.  ‘Transgender’ is an umbrella term for people whose gender identity is different from the sex assigned at birth; ‘gender identity’ is one’s innermost concept of self as male, female, a blend of both, or neither.   Transgender/gender non-conforming people experience gender dysphoria, a clinically significant distress recognized by the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM) caused by a person’s assigned birth gender differing from the one with which they identify. This leads to […]

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.